News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Urovalve's CEO Dr. Harvey Homan Appointed to National Institutes of Health (NIH)'s Center for Scientific Review (CSR)



3/15/2010 10:27:14 AM

NEWARK, N.J.--(BUSINESS WIRE)--Urovalve, a medical device company focused on creating products for urinary flow and control, announced today that its president and CEO, Harvey Homan, Ph.D., has been appointed to the National Institutes of Health’s Center for Scientific Review advisory panel for Urology and Small Business.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES